Differential Healing Responses in Polymer- and Nonpolymer-Based Sirolimus-Eluting Stents

JACC: Cardiovascular Interventions

Volumn 1, Issue 5, 2008, Pages 535-544

  John, Michael C ^a   Wessely, Rainer ^c   Kastrati, Adnan ^c   Schömig, Albert ^c   Joner, Michael ^b   Uchihashi, Mayu ^a   Crimins, Johanna ^a   Lajoie, Scott ^a   Kolodgie, Frank D ^b   Gold, Herman K ^a   Virmani, Renu ^b   Finn, Aloke V ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b CVPATH INSTITUTE   (United States)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

endothelium; polymer; stents

Indexed keywords

ESTRADIOL; METAL; POLYMER; RAPAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG COATING; DRUG ELUTING STENT; EOSINOPHIL COUNT; EXPERIMENTAL MODEL; HISTOPATHOLOGY; ILIAC ARTERY; NONHUMAN; PRIORITY JOURNAL; RABBIT; SCANNING ELECTRON MICROSCOPY; WOUND HEALING;

ANGIOPLASTY, BALLOON; ANIMALS; CARDIOVASCULAR AGENTS; CYTOKINES; DRUG-ELUTING STENTS; FIBRINOLYTIC AGENTS; ILIAC ARTERY; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; METALS; MICROSCOPY, ELECTRON, SCANNING; MODELS, ANIMAL; ORGAN CULTURE TECHNIQUES; POLYMERS; PROSTHESIS DESIGN; RABBITS; SIROLIMUS; STENTS; WOUND HEALING;

EID: 54049093613     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2008.08.004     Document Type: Article

References (26)

1. Pfisterer M., Brunner-La Rocca H.P., et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 48 (2006) 2584-2591
2. Joner M., Finn A.V., Farb A., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48 (2006) 193-202
3. Finn A.V., Kolodgie F.D., Harnek J., et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 112 (2005) 270-278
4. Virmani R., Guagliumi G., Farb A., et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?. Circulation 109 (2004) 701-705
5. Carter A.J., Aggarwal M., Kopia G.A., et al. Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model. Cardiovasc Res 63 (2004) 617-624
6. Hoye A., Iakovou I., Ge L., et al. Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome. J Am Coll Cardiol 47 (2006) 1949-1958
7. Kuchulakanti P.K., Chu W.W., Torguson R., et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 113 (2006) 1108-1113
8. Takano M., Ohba T., Inami S., Seimiya K., Sakai S., and Mizuno K. Angioscopic differences in neointimal coverage and in persistence of thrombus between sirolimus-eluting stents and bare metal stents after a 6-month implantation. Eur Heart J 27 (2006) 2189-2195
9. Wessely R., Hausleiter J., Michaelis C., et al. Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating. Arterioscler Thromb Vasc Biol 25 (2005) 748-753
10. Mehilli J., Kastrati A., Wessely R., et al. Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss. Circulation 113 (2006) 273-279
11. Brouchet L., Krust A., Dupont S., Chambon P., Bayard F., and Arnal J.F. Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta. Circulation 103 (2001) 423-428
12. Adriaenssens T., Mehilli J., Wessely R., et al. Does addition of estradiol improve the efficacy of a rapamycin-eluting stent?. Results of the ISAR-PEACE randomized trial. J Am Coll Cardiol 49 (2007) 1265-1271
13. Hausleiter J., Kastrati A., Wessely R., et al. Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymer-free, on-site stent coating. Eur Heart J 26 (2005) 1475-1481
14. Farb A., Tang A.L., Shroff S., Sweet W., and Virmani R. Neointimal responses 3 months after (32)P beta-emitting stent placement. Int J Radiat Oncol Biol Phys 48 (2000) 889-898
15. Klugherz B.D., Llanos G., Lieuallen W., et al. Twenty-eight-day efficacy and pharmacokinetics of the sirolimus-eluting stent. Cor Artery Dis 13 (2002) 183-188
16. Pache J., Kastrati A., Mehilli J., et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol 41 (2003) 1283-1288
17. Finn A.V., Nakazawa G., Joner M., et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 27 (2007) 1500-1510
18. Marx S.O., Jayaraman T., Go L.O., and Marks A.R. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res 76 (1995) 412-417
19. Vinals F., Chambard J.C., and Pouyssegur J. p70 S6 kinase-mediated protein synthesis is a critical step for vascular endothelial cell proliferation. J Biol Chem 274 (1999) 26776-26782
20. New G., Moses J.W., Roubin G.S., et al. Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model. Catheter Cardiovasc Interv 57 (2002) 266-271
21. Stanley E.R., Berg K.L., Einstein D.B., Lee P.S., and Yeung Y.G. The biology and action of colony stimulating factor-1. Stem Cells 12 Suppl 1 (1994) 15-24 discussion 25
22. Fang Y., Gong S.J., Xu Y.H., Hambly B.D., and Bao S. Impaired cutaneous wound healing in granulocyte/macrophage colony-stimulating factor knockout mice. Br J Dermatol 157 (2007) 458-465
23. Wysocki S.J., Zheng M.H., Smith A., and Norman P.E. Vascular endothelial growth factor (VEGF) expression during arterial repair in the pig. Eur J Vasc Endovasc Surg 15 (1998) 225-230
24. Zhao Q., Ishibashi M., Hiasa K., Tan C., Takeshita A., and Egashira K. Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling. Hypertension 44 (2004) 264-270
25. Concina P., Sordello S., Barbacanne M.A., et al. The mitogenic effect of 17beta-estradiol on in vitro endothelial cell proliferation and on in vivo reendothelialization are both dependent on vascular endothelial growth factor. J Vasc Res 37 (2000) 202-208
26. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323